2Vardiman JW,Harris NL,Brunning RD,et al.The World Health Organization(WHO)classification of the myeloid neoplasms.Blood,2002,100:2292-2302.
3van Dongen JJM,Macintyre EA,Gabert JA,et al.Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease.Leukemia,1999,13:1901-1928.
4Mitterbauer M,Kusec R,Schwarzinger I,et al.Comparison of karyotype analysis and RT-PCR for AML1/ETO in 204 unselected patients with AML.Ann Hematol,1998,76:139-143.
5Nguyen S,Leblanc T,Fenaux P,et al.A white blood cell index as the main prognostic factor in t(8;21) acute myeloid leukemia(AML):a survey of 161 cases from the French AML intergroup.Blood,2002,99:3517-3523.
6Nishii K,Usui E,Katayama N,et al.Characteristics of t(8;21) acute myeloid leukemia (AML) with additional chromosomal abnormality:concomitant trisomy 4 may constitute a distinctiv subtype of t(8;21) AML.Leukemia,2003,17:731-737.
7Wong KF,Kwong YL,So CC.Translocation (8;20;21)(q22;q13;q22) in acute myeloblastic leukemia with maturation:a variant form of t(8;21).Cancer Genet Cytogenet,1998,101:39-41.
